Connection

Carol Feghali-Bostwick to Cells, Cultured

This is a "connection" page, showing publications Carol Feghali-Bostwick has written about Cells, Cultured.
Connection Strength

1.840
  1. Reduced Cathepsin L expression and secretion into the extracellular milieu contribute to lung fibrosis in systemic sclerosis. Rheumatology (Oxford). 2023 03 01; 62(3):1306-1316.
    View in: PubMed
    Score: 0.142
  2. Antifibrotic factor KLF4 is repressed by the miR-10/TFAP2A/TBX5 axis in dermal fibroblasts: insights from twins discordant for systemic sclerosis. Ann Rheum Dis. 2022 02; 81(2):268-277.
    View in: PubMed
    Score: 0.130
  3. Elucidating the cellular mechanism for E2-induced dermal fibrosis. Arthritis Res Ther. 2021 02 27; 23(1):68.
    View in: PubMed
    Score: 0.124
  4. Phenotypic Characterization of Transgenic Mice Expressing Human IGFBP-5. Int J Mol Sci. 2020 Dec 30; 22(1).
    View in: PubMed
    Score: 0.122
  5. Insulin-like growth factor (IGF)-II- mediated fibrosis in pathogenic lung conditions. PLoS One. 2019; 14(11):e0225422.
    View in: PubMed
    Score: 0.113
  6. NADPH oxidase-mediated induction of reactive oxygen species and extracellular matrix deposition by insulin-like growth factor binding protein-5. Am J Physiol Lung Cell Mol Physiol. 2019 04 01; 316(4):L644-L655.
    View in: PubMed
    Score: 0.108
  7. A Human Skin Model Recapitulates Systemic Sclerosis Dermal Fibrosis and Identifies COL22A1 as a TGF? Early Response Gene that Mediates Fibroblast to Myofibroblast Transition. Genes (Basel). 2019 01 22; 10(2).
    View in: PubMed
    Score: 0.107
  8. Estradiol promotes the development of a fibrotic phenotype and is increased in the serum of patients with systemic sclerosis. Arthritis Res Ther. 2013 Jan 10; 15(1):R10.
    View in: PubMed
    Score: 0.070
  9. Syndecan-2 is a novel target of insulin-like growth factor binding protein-3 and is over-expressed in fibrosis. PLoS One. 2012; 7(8):e43049.
    View in: PubMed
    Score: 0.068
  10. Localized expression of tenascin in systemic sclerosis-associated pulmonary fibrosis and its regulation by insulin-like growth factor binding protein 3. Arthritis Rheum. 2012 Jan; 64(1):272-80.
    View in: PubMed
    Score: 0.066
  11. Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathways. Am J Pathol. 2008 Jun; 172(6):1580-90.
    View in: PubMed
    Score: 0.051
  12. Insulin-like growth factor binding protein 5 induces skin fibrosis: A novel murine model for dermal fibrosis. Arthritis Rheum. 2006 Sep; 54(9):3001-10.
    View in: PubMed
    Score: 0.045
  13. Monozygotic twins clinically discordant for scleroderma show concordance for fibroblast gene expression profiles. Arthritis Rheum. 2005 Oct; 52(10):3305-14.
    View in: PubMed
    Score: 0.043
  14. Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition. Am J Pathol. 2005 Feb; 166(2):399-407.
    View in: PubMed
    Score: 0.041
  15. CD70 Activation Decreases Pulmonary Fibroblast Production of Extracellular Matrix Proteins. Am J Respir Cell Mol Biol. 2020 08; 63(2):255-265.
    View in: PubMed
    Score: 0.030
  16. Long intergenic non-coding RNAs regulate human lung fibroblast function: Implications for idiopathic pulmonary fibrosis. Sci Rep. 2019 04 15; 9(1):6020.
    View in: PubMed
    Score: 0.027
  17. Long Non-coding RNAs Are Central Regulators of the IL-1?-Induced Inflammatory Response in Normal and Idiopathic Pulmonary Lung Fibroblasts. Front Immunol. 2018; 9:2906.
    View in: PubMed
    Score: 0.027
  18. Reduced microRNA-503 expression augments lung fibroblast VEGF production in chronic obstructive pulmonary disease. PLoS One. 2017; 12(9):e0184039.
    View in: PubMed
    Score: 0.024
  19. Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis. Arthritis Res Ther. 2017 06 17; 19(1):144.
    View in: PubMed
    Score: 0.024
  20. The role of microRNA-155/liver X receptor pathway in experimental and idiopathic pulmonary fibrosis. J Allergy Clin Immunol. 2017 Jun; 139(6):1946-1956.
    View in: PubMed
    Score: 0.023
  21. Tenascin-C drives persistence of organ fibrosis. Nat Commun. 2016 06 03; 7:11703.
    View in: PubMed
    Score: 0.022
  22. Fibroblast Activation Protein (FAP) Accelerates Collagen Degradation and Clearance from Lungs in Mice. J Biol Chem. 2016 Apr 08; 291(15):8070-89.
    View in: PubMed
    Score: 0.022
  23. Lipoxin A4 Attenuates Constitutive and TGF-?1-Dependent Profibrotic Activity in Human Lung Myofibroblasts. J Immunol. 2015 Sep 15; 195(6):2852-60.
    View in: PubMed
    Score: 0.021
  24. Induced pluripotent stem cells model personalized variations in liver disease resulting from a1-antitrypsin deficiency. Hepatology. 2015 Jul; 62(1):147-57.
    View in: PubMed
    Score: 0.021
  25. Effect of culture conditions on microRNA expression in primary adult control and COPD lung fibroblasts in vitro. In Vitro Cell Dev Biol Anim. 2015 Apr; 51(4):390-9.
    View in: PubMed
    Score: 0.020
  26. Increased constitutive aSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is KCa3.1-dependent. Respir Res. 2014 Dec 05; 15:155.
    View in: PubMed
    Score: 0.020
  27. Fibroblasts that resist cigarette smoke-induced senescence acquire profibrotic phenotypes. Am J Physiol Lung Cell Mol Physiol. 2014 Sep 01; 307(5):L364-73.
    View in: PubMed
    Score: 0.020
  28. A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis. FASEB J. 2014 Jul; 28(7):3183-96.
    View in: PubMed
    Score: 0.019
  29. Vitamin D modulates prostaglandin E2 synthesis and degradation in human lung fibroblasts. Am J Respir Cell Mol Biol. 2014 Jan; 50(1):40-50.
    View in: PubMed
    Score: 0.019
  30. Overexpression of c-Met and CD44v6 receptors contributes to autocrine TGF-?1 signaling in interstitial lung disease. J Biol Chem. 2014 Mar 14; 289(11):7856-72.
    View in: PubMed
    Score: 0.019
  31. Phosphodiesterase-4 inhibition augments human lung fibroblast vascular endothelial growth factor production induced by prostaglandin E2. Am J Respir Cell Mol Biol. 2013 Oct; 49(4):571-81.
    View in: PubMed
    Score: 0.019
  32. Telomerase and telomere length in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2013 Aug; 49(2):260-8.
    View in: PubMed
    Score: 0.018
  33. Transcriptional regulation of increased CCL2 expression in pulmonary fibrosis involves nuclear factor-?B and activator protein-1. Int J Biochem Cell Biol. 2013 Jul; 45(7):1366-76.
    View in: PubMed
    Score: 0.018
  34. Expression of c-myc, c-myb, and c-sis in fibroblasts from affected and unaffected skin of patients with systemic sclerosis. Autoimmunity. 1993; 16(3):167-71.
    View in: PubMed
    Score: 0.018
  35. Mitochondrial reactive oxygen species regulate transforming growth factor-? signaling. J Biol Chem. 2013 Jan 11; 288(2):770-7.
    View in: PubMed
    Score: 0.017
  36. Toll-like receptor 4 signaling augments transforming growth factor-? responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma. Am J Pathol. 2013 Jan; 182(1):192-205.
    View in: PubMed
    Score: 0.017
  37. Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma. J Rheumatol. 1992 Aug; 19(8):1207-11.
    View in: PubMed
    Score: 0.017
  38. Mechanisms of pathogenesis in scleroderma. II. Effects of serum and conditioned culture medium on fibroblast function in scleroderma. J Rheumatol. 1992 Aug; 19(8):1212-9.
    View in: PubMed
    Score: 0.017
  39. The early growth response gene Egr2 (Alias Krox20) is a novel transcriptional target of transforming growth factor-? that is up-regulated in systemic sclerosis and mediates profibrotic responses. Am J Pathol. 2011 May; 178(5):2077-90.
    View in: PubMed
    Score: 0.016
  40. PPAR? downregulation by TGF? in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis. PLoS One. 2010 Nov 02; 5(11):e13778.
    View in: PubMed
    Score: 0.015
  41. Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis. Mol Cell Biol. 2009 Aug; 29(15):4325-39.
    View in: PubMed
    Score: 0.014
  42. MAPK pathway mediates EGR-1-HSP70-dependent cigarette smoke-induced chemokine production. Am J Physiol Lung Cell Mol Physiol. 2007 May; 292(5):L1297-303.
    View in: PubMed
    Score: 0.012
  43. Hepatocyte growth factor and other fibroblast secretions modulate the phenotype of human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2007 Jun; 292(6):L1352-60.
    View in: PubMed
    Score: 0.012
  44. Cigarette smoke stimulates matrix metalloproteinase-2 activity via EGR-1 in human lung fibroblasts. Am J Respir Cell Mol Biol. 2007 Apr; 36(4):480-90.
    View in: PubMed
    Score: 0.011
  45. Distinct PKC isoforms mediate cell survival and DNA synthesis in thrombin-induced myofibroblasts. Am J Physiol Lung Cell Mol Physiol. 2005 Jan; 288(1):L190-201.
    View in: PubMed
    Score: 0.010
  46. A nuclear target for interleukin-1alpha: interaction with the growth suppressor necdin modulates proliferation and collagen expression. Proc Natl Acad Sci U S A. 2003 Aug 19; 100(17):10008-13.
    View in: PubMed
    Score: 0.009
  47. Systemic sclerosis (scleroderma): specific autoantigen genes are selectively overexpressed in scleroderma fibroblasts. J Immunol. 2001 Dec 15; 167(12):7126-33.
    View in: PubMed
    Score: 0.008
  48. IFN-gamma induces a p91/Stat1 alpha-related transcription factor with distinct activation and binding properties. J Immunol. 1995 Oct 01; 155(7):3472-80.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.